Our Full Service CRO Expedites Precision Oncology Clinical Trial Enrollment
Our Full Service CRO Expedites Precision Oncology Clinical Trial Enrollment
Our Comprehensive Platform & Direct Access to Patients Reduces Development Time
From Genomics to proteomics our state-of-the-art Laboratory provides an extensive suite of multi-omics offerings to bio-pharma, university and government partners with key datasets for a critical, integrated, and holistic understanding of their disease populat
Our Comprehensive Platform & Direct Access to Patients Reduces Development Time
From Genomics to proteomics our state-of-the-art Laboratory provides an extensive suite of multi-omics offerings to bio-pharma, university and government partners with key datasets for a critical, integrated, and holistic understanding of their disease populations.
Playing a key role in expediting:
Our Data Mirrors Cancer Biology.
Our biopharma clients and partners have the power to accelerate therapy development with real-world multi-modal data to uncover new insights across the research and development spectrum to make smarter decisions and launch molecules more efficiently.
Our Data Mirrors Cancer Biology.
Our biopharma clients and partners have the power to accelerate therapy development with real-world multi-modal data to uncover new insights across the research and development spectrum to make smarter decisions and launch molecules more efficiently.
Physician Scientist with 25 years of experience in bio-medical science and healthcare delivery
Domain experience in Precision Oncology & Medical Data
Training & experience at Cornell & Columbia University Hospitals
25+ years experience in Healthcare Company Building and Execution – Business and Team Builder
Experience in business development – fund raising to partnership/exit
Maximizing Shareholder Value
Launched and Relaunched over two dozen companies and products with success
Mr. Ranjeet Nabha is a senior executive who has led organizations in the areas of Private Equity, Technology and Corporate Advisory. His areas of expertise include investment management, business development, general management, and technology entrepreneurship.
Prior to these roles, he was a Managing Director at WL Ross & Co. a global priv
Mr. Ranjeet Nabha is a senior executive who has led organizations in the areas of Private Equity, Technology and Corporate Advisory. His areas of expertise include investment management, business development, general management, and technology entrepreneurship.
Prior to these roles, he was a Managing Director at WL Ross & Co. a global private equity firm, and CEO of WL Ross’ private equity business in India.
He also served as Vice President at J.P. Morgan &Co. in New York where he advised on restructurings,
mergers/acquisitions, capital raisings and privatizations.
Mr. Nabha earned his MBA at the Tuck School of Business at Dartmouth College.
Over 40 years of diversified experience, specializing in pharmaceuticals, biotechnology, diagnostics, medical devices, and healthcare services
Proven strengths in leveraging scientific knowledge, analytical/strategic thinking,
market/customer understanding, and the leadership skills to transform insights
into innovative commercial strategi
Over 40 years of diversified experience, specializing in pharmaceuticals, biotechnology, diagnostics, medical devices, and healthcare services
Proven strengths in leveraging scientific knowledge, analytical/strategic thinking,
market/customer understanding, and the leadership skills to transform insights
into innovative commercial strategies and tactics
Played an instrumental role in numerous highly successful product and brand launches, with numerous awards for business excellence
Marketing expertise across entire lifecycle continuum. Extensive experience across several therapeutic areas.
Show Less
10 Hope Street, Williamsburg, Brooklyn, New York, United States
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.